Status:
UNKNOWN
A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients
Lead Sponsor:
National Taiwan University Hospital Hsin-Chu Branch
Collaborating Sponsors:
National Yang Ming Chiao Tung University
Conditions:
Breast Cancer
Sentinel Lymph Node
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study aims for evaluating near infrared zone II imaging in sentinel lymph node mapping in breast cancer patients.
Detailed Description
Multi-wavelength fluorescence has been surveyed in various fields of surgery. However, it was still under investigation, and has not been matured for clinical use. This study will evaluate near infrar...
Eligibility Criteria
Inclusion
- Breast cancer, adults
Exclusion
- Patient aged \< 20 years old
- Primary lesion without indication of sentinel lymph node biopsy in current guidelines (Low-risk ductal carcinoma in situ or metastatic breast cancer)
- Patient who is allergic to primary tracers (including Tc99m and blue dye)
- Patient who is allergic to indocyanine green
Key Trial Info
Start Date :
April 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 7 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05365191
Start Date
April 8 2022
End Date
April 7 2023
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Hsin-Chu Branch Biomedical Park Hospital
Zhubei, HsinChu County, Taiwan, 302